Pandemic onset stalled reduction of benzodiazepine use among older Americans, says study
A decade-long study from Columbia University reveals that the steady decline in benzodiazepine prescriptions for older Americans stalled following the onset of the COVID-19 pandemic. Researchers noted an increase in usage among adults aged 75 and older, raising concerns due to the medication's known risks of cognitive impairment and falls.
Why it matters
The findings highlight a significant public health setback in medication safety for vulnerable elderly populations, suggesting the pandemic disrupted long-term efforts to reduce reliance on high-risk drugs.
by Columbia University's Mailman School of Public Health
The article reports on peer-reviewed scientific findings without political framing or loaded language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in